Proteome Sciences PLC Holdings in Company / PDMR Shareholding (2160T)
03 January 2017 - 1:34PM
UK Regulatory
TIDMPRM
RNS Number : 2160T
Proteome Sciences PLC
03 January 2017
Proteome Sciences plc
(the "Company")
Holdings in Company and PDMR Shareholding
Proteome Sciences plc (AIM:PRM) received notification from
Vulpes Life Science Fund ("Vulpes"), of which Martin Diggle, a
non-executive director of the Company, is a director and partner,
that on 28, 29 and 30 December 2016, it purchased 265,000, 250,000
and 350,000 ordinary shares of 1 pence each ("Ordinary Shares")
respectively, at an average price of 5.74 pence per Ordinary Share
(the "Transaction"). Following the Transaction, Vulpes (and Mr
Diggle) have a beneficial interest in 53,838,125 Ordinary Shares,
representing approximately 18.29% of the current issued share
capital of the Company.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------------
a) Name Vulpes Life Science Fund
--- ------------------------------- ---------------------------------
2. Reason for the Notification
--- ------------------------------------------------------------------
a) Position/status Martin Diggle, non-executive
director of the Company is
a director and partner of
Vulpes Life Science Fund
--- ------------------------------- ---------------------------------
b) Initial notification/Amendment Initial notification
--- ------------------------------- ---------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ------------------------------------------------------------------
a) Name Proteome Sciences plc
--- ------------------------------- ---------------------------------
b) LEI n/a
--- ------------------------------- ---------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ------------------------------------------------------------------
a) Description of Ordinary Shares of 1p each
the Financial
instrument, type
of instrument
---
Identification GB0003104196
code
--- ------------------------------- ---------------------------------
b) Nature of the Purchase of Ordinary Shares
transaction
--- ------------------------------- ---------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
28 December 2016 5.75p 265,000
29 December 2016 5.75p 250,000
30 December 2016 5.725p 350,000
--------- ----------
--- ------------------------------- ---------------------------------
d) Aggregated information:
* Aggregated volume 865,000 Ordinary Shares of
1 pence each purchased at
an average price of 5.74 pence
* Price per Ordinary Share
--- ------------------------------- ---------------------------------
e) Date of the transaction 28 December 2016, 29 December
2016 and 30 December 2016
--- ------------------------------- ---------------------------------
f) Place of the London Stock Exchange, AIM
transaction Market (XLON)
--- ------------------------------- ---------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBXGDBDXGBGRX
(END) Dow Jones Newswires
January 03, 2017 08:34 ET (13:34 GMT)